combination drug: levodopa / carbidopa
- CSA schedule: none
- DEA number: none
- MEDLINEplus® Drug Information
U.S. Preparations:
- Carbidopa / Levodopa Tablets, USP (Endo
Pharmaceuticals Inc.) FDA approved indications: treatment
of idiopathic Parkinson's disease, postencephalitic
Parkinsonism
and Parkinsonism
which may follow toxic injury
U.S. Prescribing information
- Parcopa™ (Schwarz) FDA approved indications: treatment
of idiopathic Parkinson's disease
(paralysis agitans), postencephalitic
Parkinson's
disease, and symptomatic Parkinsonism
which may follow injury to the nervous system by carbon monoxide
intoxication and/or manganese intoxication.
U.S. Prescribing information 8.30.2004 -
Sinemet®
CR (Bristol-Myers Squibb) FDA approved indications: treatment
of idiopathic Parkinson's disease, postencephalitic
Parkinsonism
and Parkinsonism
which may follow toxic injury
U.S. Prescribing information - Sinemet® (Bristol-Myers Squibb) FDA approved indications: treatment
of idiopathic Parkinson's disease, postencephalitic
Parkinsonism
and Parkinsonism
which may follow toxic injury
U.S. Prescribing information
- Stalevo™ (Novartis) combination with entacapone